BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
2051
DELISTED
Meridian Bioscience Inc
VIVO
| $90.2K | ﹤0.01% |
3,875
-13,939
| -78% | -$325K |
|
|
ACOR
2052
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $89.9K | ﹤0.01% |
1,020
+859
| +534% | +$75.7K |
|
|
INOV
2053
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $89.6K | ﹤0.01% |
4,650
-58,424
| -93% | -$1.13M |
|
|
TPIC
2054
DELISTED
TPI Composites
TPIC
| $88.5K | ﹤0.01% |
3,787
-5,159
| -58% | -$121K |
|
2055
Plains All American Pipeline
PAA
$12.3B
| $87K | ﹤0.01% |
9,836
-13,252
| -57% | -$117K |
|
2056
Palomar
PLMR
$3.13B
| $86.8K | ﹤0.01% |
1,012
-4,509
| -82% | -$387K |
|
2057
Catalyst Pharmaceutical
CPRX
$2.44B
| $86.8K | ﹤0.01% |
18,783
-62,624
| -77% | -$289K |
|
2058
Eagle Bancorp
EGBN
$615M
| $86.6K | ﹤0.01% |
2,643
-11,250
| -81% | -$368K |
|
|
FBC
2059
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $86.6K | ﹤0.01% |
2,941
-12,664
| -81% | -$373K |
|
2060
City Holding Co
CHCO
$1.83B
| $86.5K | ﹤0.01% |
1,327
-5,398
| -80% | -$352K |
|
|
NAV
2061
DELISTED
Navistar International
NAV
| $86.2K | ﹤0.01% |
3,057
-13,397
| -81% | -$378K |
|
|
EGRX
2062
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $86K | ﹤0.01% |
1,793
-20,193
| -92% | -$969K |
|
2063
SPDR S&P Pharmaceuticals ETF
XPH
$184M
| $86K | ﹤0.01% |
+2,000
| New | +$86K |
|
2064
Universal Corp
UVV
$1.38B
| $85.8K | ﹤0.01% |
2,019
-8,488
| -81% | -$361K |
|
|
BHR
2065
Braemar Hotels & Resorts
BHR
$203M
| $85.7K | ﹤0.01% |
29,967
+20,713
| +224% | +$59.2K |
|
2066
Vericel Corp
VCEL
$1.62B
| $85.7K | ﹤0.01% |
6,200
-15,497
| -71% | -$214K |
|
2067
McGrath RentCorp
MGRC
$3.01B
| $85.7K | ﹤0.01% |
1,586
-6,461
| -80% | -$349K |
|
|
WIRE
2068
DELISTED
Encore Wire Corp
WIRE
| $85.6K | ﹤0.01% |
1,754
-6,887
| -80% | -$336K |
|
2069
Hilltop Holdings
HTH
$2.18B
| $85.6K | ﹤0.01% |
4,637
-20,493
| -82% | -$378K |
|
2070
WesBanco
WSBC
$3.03B
| $85.5K | ﹤0.01% |
4,209
-50,402
| -92% | -$1.02M |
|
2071
Arcus Biosciences
RCUS
$1.23B
| $85.4K | ﹤0.01% |
3,453
-6,574
| -66% | -$163K |
|
2072
Employers Holdings
EIG
$983M
| $85.4K | ﹤0.01% |
2,832
-11,228
| -80% | -$339K |
|
2073
ProAssurance
PRA
$1.22B
| $85K | ﹤0.01% |
5,872
-16,721
| -74% | -$242K |
|
|
LTHM
2074
DELISTED
Livent Corporation
LTHM
| $85K | ﹤0.01% |
13,792
-48,133
| -78% | -$297K |
|
|
FOE
2075
DELISTED
Ferro Corporation
FOE
| $84.5K | ﹤0.01% |
7,081
-27,306
| -79% | -$326K |
|